Semaglutide Acetate is a modified peptide containing hydrophobic substitutions and stabilizing motifs that promote extended helical conformations. Researchers employ it to investigate backbone stabilization, side-chain packing, and receptor-mimicking interactions. The sequence's aliphatic and aromatic diversity enhances structural versatility. Its acetate form supports consistent analytical handling.
CAT No: R2197
CAS No:1997361-85-9
Synonyms/Alias:Semaglutide Acetate;1997361-85-9;Semaglutide (acetate);Semaglutide acetate - Bio-X trade mark;BS181345;BS183957;
Semaglutide Acetate is a synthetic peptide analog of the human glucagon-like peptide-1 (GLP-1), engineered to exhibit enhanced stability and prolonged biological activity compared to endogenous GLP-1. As a member of the incretin mimetic peptide class, it plays a pivotal role in modulating glucose metabolism and insulin secretion pathways. Its molecular architecture incorporates strategic amino acid substitutions and acylation, which contribute to its resistance against enzymatic degradation and extend its half-life. Semaglutide Acetate has become a valuable tool in biochemical research, particularly for studies focusing on peptide hormone signaling, metabolic regulation, and receptor-ligand interactions. Researchers leverage its well-characterized pharmacological profile to advance understanding of GLP-1 receptor biology and related metabolic processes.
Receptor Pharmacology: In receptor pharmacology research, Semaglutide Acetate serves as a model GLP-1 receptor agonist for in vitro and ex vivo studies. Scientists utilize it to characterize GLP-1 receptor binding kinetics, signal transduction mechanisms, and downstream cellular responses. Its high affinity and receptor selectivity make it suitable for dissecting the nuances of receptor activation, G protein coupling, and second messenger cascades in various cell types, contributing to a deeper understanding of incretin receptor pharmacodynamics.
Metabolic Pathway Analysis: The compound is frequently employed in metabolic research to elucidate the molecular mechanisms governing glucose homeostasis and insulin secretion. By using Semaglutide Acetate in cellular assays and animal models, investigators can probe the effects of GLP-1 receptor activation on pancreatic beta cell function, insulin gene expression, and glucose-stimulated insulin release. Such studies are instrumental in mapping the intricate signaling networks that control energy balance and carbohydrate metabolism.
Peptide Stability and Modification Studies: Semaglutide Acetate's unique structural modifications make it an exemplary system for investigating peptide stability, proteolytic resistance, and structure-activity relationships. Researchers interested in peptide drug design and optimization often use it as a reference molecule to assess the impact of specific amino acid substitutions and chemical modifications on peptide pharmacokinetics and bioactivity. These insights inform the rational development of next-generation peptide therapeutics with improved metabolic profiles.
Analytical Method Development: The peptide is also utilized as a standard or model analyte in the development and validation of analytical techniques such as liquid chromatography-mass spectrometry (LC-MS) and enzyme-linked immunosorbent assays (ELISA). Its defined sequence and physicochemical properties enable precise calibration and sensitivity testing of analytical platforms designed for peptide quantification, stability assessment, and impurity profiling. This application supports advancements in peptide analytics and quality control processes within research and manufacturing environments.
Peptide-Protein Interaction Research: Semaglutide Acetate is used to investigate the interactions between peptide hormones and their associated binding proteins or receptors. Employing advanced biophysical and biochemical assays, researchers can explore the conformational dynamics, binding affinities, and structural determinants that govern GLP-1 analog recognition by its receptor and related proteins. Such studies provide valuable insights into the molecular basis of peptide-receptor specificity and inform the design of novel peptide-based ligands for targeted research applications.
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More